SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (8091)12/20/1998 1:04:00 AM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Catheter problems:

ama-assn.org:80/special/hiv/newsline/reuters/12154605.htm



To: Cacaito who wrote (8091)12/20/1998 2:36:00 AM
From: Tharos  Read Replies (2) | Respond to of 17367
 
Well, I do look for sepsis control and antibiotic synergy to be two potential markets for Neuprex. Even more exciting is the discovery that hu1124 has a positive effect on T-cells. The more I study, the more I become convinced that BPI plays a key role in the body and has potential to be used in AIDS and cancer treatments.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News